Alnylam Pharmaceuticals
ALNY
#637
Rank
A$49.44 B
Marketcap
$381.92
Share price
-0.07%
Change (1 day)
70.54%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company